In prostate cancer, PSMA-expressing cells consequently display increased folate uptake and rapid proliferation [8-10], as PSMA-catalyzed glutamate release activates phospholipase C pathway and promotes tumor growth [11, 12]. Here, FOLH1 is linked to prostate cancer.